Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Warady BA"" wg kryterium: Autor


Tytuł :
The copy number variation landscape of congenital anomalies of the kidney and urinary tract.
Autorzy :
Verbitsky, M
Westland, R
Perez, A
Kiryluk, K
Liu, Q
Krithivasan, P
Mitrotti, A
Fasel, Da
Batourina, E
Sampson, Mg
Bodria, M
Werth, M
Kao, C
Martino, J
Capone, Vp
Vivante, A
Shril, S
Kil, Bh
Marasà, M
Zhang, Jy
Na, Yj
Lim, Ty
Ahram, D
Weng, Pl
Heinzen, El
Carrea, A
Piaggio, G
Gesualdo, L
Manca, V
Masnata, G
Gigante, M
Cusi, D
Izzi, C
Scolari, F
van Wijk, Jae
Saraga, M
Santoro, D
Conti, G
Zamboli, P
White, H
Drozdz, D
Zachwieja, K
Miklaszewska, M
Tkaczyk, M
Tomczyk, D
Krakowska, A
Sikora, P
Jarmoliński, T
Borszewska-Kornacka, Mk
Pawluch, R
Szczepanska, M
Adamczyk, P
Mizerska-Wasiak, M
Krzemien, G
Szmigielska, A
Zaniew, M
Dobson, Mg
Darlow, Jm
Puri, P
Barton, De
Furth, Sl
Warady, Ba
Gucev, Z
Lozanovski, Vj
Tasic, V
Pisani, I
Allegri, L
Rodas, Lm
Campistol, Jm
Jeanpierre, C
Alam, S
Casale, P
Wong, Cs
Lin, F
Miranda, Dm
Oliveira, Ea
Simões-E-Silva, Ac
Barasch, Jm
Levy, B
Wu, N
Hildebrandt, F
Ghiggeri, Gm
Latos-Bielenska, A
Materna-Kiryluk, A
Zhang, F
Hakonarson, H
Papaioannou, Ve
Mendelsohn, Cl
Gharavi, Ag
Sanna-Cherchi, S
Pokaż więcej
Opis pliku :
ELETTRONICO
Relacje :
info:eu-repo/semantics/altIdentifier/pmid/30578417; info:eu-repo/semantics/altIdentifier/wos/WOS:000454108800019; info:eu-repo/semantics/altIdentifier/hdl/11379/516620; volume:51; issue:1; firstpage:117; lastpage:127; numberofpages:11; journal:NATURE GENETICS; urn:ISSN:1061-4036; http://hdl.handle.net/11379/516620; 2-s2.0-85058908326
Dostępność :
https://doi.org/10.1038/s41588-018-0281-y
http://hdl.handle.net/11379/516620
Czasopismo naukowe
Tytuł :
Reducción de moléculas medianas con hemodiálisis expandida a diferentes flujos de dializado ; Reduction of medium molecules with expanded hemodialysis at different dialysate flows
Autorzy :
Ramos Galvis, Leidy Carolina
Gutiérrez Castilla, Juan Felipe
reponame:Repositorio Institucional EdocUR ; instname:Universidad del Rosario ; Kashiwagi T
Sato K
Kawakami S
Kiyomoto M
Enomoto M
Suzuki T
et al. Effects of reduced dialysis fluid flow in hemodialysis. J Nippon Med Sch [Internet]. 2013 [cited 2018 Sep 26];80(2):119–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23657065 ; Tarrass F
Benjelloun M
Benjelloun O. Recycling Wastewater After Hemodialysis: An Environmental Analysis for Alternative Water Sources in Arid Regions. Am J Kidney Dis. 2008;52(1):154–8. ; Jha V
Garcia-Garcia G
Iseki K
Li Z
Naicker S
Plattner B
et al. Chronic kidney disease: global dimension and perspectives. Lancet [Internet]. 2013 Jul 20 [cited 2018 Sep 26];382(9888):260–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23727169 ; Prasad N
Jha V. Hemodialysis in Asia. Kidney Dis (Basel
Switzerland) [Internet]. 2015 Dec [cited 2018 Sep 26];1(3):165–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27536677 ; Hoenich NA
Levin R
Ronco C. Water for haemodialysis and related therapies: recent standards and emerging issues. Blood Purif. 2010;29(2):81–5. ; Agar JWM. Reusing dialysis wastewater: the elephant in the room. Vol. 52
American journal of kidney diseases : the official journal of the National Kidney Foundation. United States; 2008. p. 10–2. ; DAUGIRDAS JT. Prescribing and monitoring hemodialysis in a 3-4 × /week setting. Hemodial Int [Internet]. 2008 Apr [cited 2018 Sep 26];12(2):215–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18394053 ; Ronco C
La Manna G. Expanded Hemodialysis: A New Therapy for a New Class of Membranes. In: Contributions to nephrology [Internet]. 2017 [cited 2018 Sep 26]. p. 124–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28535525 ; Ducuara D
Martínez A
Molano A
Wancjer B
Tovar JR. Effect of flow adjustment dialysate (Qd) hemodialysis on effectiveness of underweight patients. [cited 2018 Sep 26]; Available from: https://www.ingentaconnect.com/content/doaj/16927273/2013/00000011/00000002/art00003#Refs ; Molano Triviño A
Wancjer Meid B
Guzman G
Yunez Luqueta A
Beltrán J
Romero G
et al. SP491EFFECTS OF DECREASING DIALYSIS FLUID FLOW RATE ON DIALYSIS EFFICACY AND INTERDIALYTIC WEIGHT GAIN IN CHRONIC PATIENTS WITH HEMODIALYSIS - FLUGAIN Study. Nephrol Dial Transplant [Internet]. 2018 May 1 [cited 2018 Sep 26];33(suppl_1):i514–5. Available from: https://academic.oup.com/ndt/article/33/suppl_1/i514/4998454 ; Leypoldt JK
Prichard S
Chertow GM
Alvarez L. Differential Molecular Modeling Predictions of Mid and Conventional Dialysate Flows. Blood Purif. 2019;47(4):369–76. ; Molano Trivino A
Galván Á
Vesga J
Suárez A
Sanabria RM
et al. SAT-342 LONG TERM OUTCOMES OF LOWERING DIALYSATE FLOW (QD) IN A POPULATION OF CHRONIC HEMODIALYSIS IN RTS COLOMBIA. Kidney Int Reports [Internet]. 2019 Jul 1;4(7):S151–2. Available from: https://doi.org/10.1016/j.ekir.2019.05.390 ; Lowrie EG
Laird NM
Parker TF
Sargent JA. Effect of the Hemodialysis Prescription on Patient Morbidity. N Engl J Med [Internet]. 1981 Nov 12 [cited 2018 Sep 26];305(20):1176–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7027040 ; Harter HR. Review of significant findings from the National Cooperative Dialysis Study and recommendations. Kidney Int Suppl [Internet]. 1983 Apr [cited 2018 Sep 26];(13):S107-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6345891 ; Vanholder R
Schepers E
Pletinck A
Nagler E V.
Glorieux G. The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate: A Systematic Review. J Am Soc Nephrol [Internet]. 2014 Sep 1 [cited 2018 Sep 26];25(9):1897–907. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24812165 ; Locatelli F
Martin-Malo A
Hannedouche T
Loureiro A
Papadimitriou M
Wizemann V
et al. Effect of Membrane Permeability on Survival of Hemodialysis Patients. J Am Soc Nephrol [Internet]. 2009 Feb 25 [cited 2018 Sep 26];20(3):645–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19092122 ; Hakim P discussant: RM. Assessing the adequacy of dialysis. Kidney Int [Internet]. 1990 Feb 1;37(2):822–32. Available from: https://doi.org/10.1038/ki.1990.52 ; Hemodialysis Adequacy 2006 Work Group. Clinical Practice Guidelines for Hemodialysis Adequacy
Update 2006. Am J Kidney Dis [Internet]. 2006 Jul [cited 2018 Sep 26];48:S2–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16813990 ; Goldstein SL
Brem A
Warady BA
Fivush B
Frankenfield D. Comparison of single-pool and equilibrated Kt/V values for pediatric hemodialysis prescription management: analysis from the Centers for Medicare & Medicaid Services Clinical Performance Measures Project. Pediatr Nephrol. 2006 Aug;21(8):1161–6. ; Himmelfarb J
Ikizler TA. Hemodialysis. N Engl J Med [Internet]. 2010 Nov 3;363(19):1833–45. Available from: https://doi.org/10.1056/NEJMra0902710 ; Daugirdas JT
Depner TA. A nomogram approach to hemodialysis urea modeling. Am J Kidney Dis [Internet]. 1994 Jan [cited 2018 Sep 26];23(1):33–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8285195 ; Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol [Internet]. 1993 Nov [cited 2018 Sep 26];4(5):1205–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8305648 ; Besarab A
Sherman R. The relationship of recirculation to access blood flow. Am J Kidney Dis [Internet]. 1997 Feb [cited 2018 Sep 26];29(2):223–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9016893 ; Eloot S
Van Biesen W
Vanholder R. A Sad but Forgotten Truth: The Story of Slow-Moving Solutes in Fast Hemodialysis. Semin Dial [Internet]. 2012 Sep 1 [cited 2018 Sep 26];25(5):505–9. Available from: http://doi.wiley.com/10.1111/j.1525-139X.2012.01107.x ; European Best Practice Guidelines Expert Group on Hemodialysis
European Renal Association. Section II. Haemodialysis adequacy. Nephrol Dial Transplant [Internet]. 2002 [cited 2018 Sep 26];17 Suppl 7:16–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12386211 ; Glorieux G
Tattersall J. Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy. Clin Kidney J [Internet]. 2015 Aug [cited 2018 Sep 26];8(4):353–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26251699 ; Vanholder R
Glorieux G
Eloot S. Once upon a time in dialysis: the last days of Kt/V? Kidney Int [Internet]. 2015 Sep [cited 2018 Sep 26];88(3):460–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26061543 ; Powers KM
Wilkowski MJ
Helmandollar AW
Koenig KG
Bolton WK. Improved urea reduction ratio and Kt/V in large hemodialysis patients using two dialyzers in parallel. Am J Kidney Dis [Internet]. 2000 Feb [cited 2018 Sep 26];35(2):266–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10676726 ; el Akrout M
Jadoul M. [Methodology and practical use in hemodialysis of the percentage of urea reduction (PUR)]. Nephrologie [Internet]. 1995 [cited 2018 Sep 26];16(6):413–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8524448 ; Owen WF
Lew NL
Liu Y
Lowrie EG
Lazarus JM. The Urea Reduction Ratio and Serum Albumin Concentration as Predictors of Mortality in Patients Undergoing Hemodialysis. N Engl J Med [Internet]. 1993 Sep 30 [cited 2018 Sep 26];329(14):1001–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8366899 ; Held PJ
Port FK
Wolfe RA
Stannard DC
Carroll CE
Daugirdas JT
et al. The dose of hemodialysis and patient mortality. Kidney Int [Internet]. 1996 Aug [cited 2018 Sep 26];50(2):550–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8840285 ; Sehgal AR
Snow RJ
Singer ME
Amini SB
DeOreo PB
Silver MR
et al. Barriers to adequate delivery of hemodialysis. Am J Kidney Dis [Internet]. 1998 Apr [cited 2018 Sep 26];31(4):593–601. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9531174 ; Ifudu O
Mayers JD
Matthew JJ
Fowler AM
Homel P
Friedman EA. Standardized Hemodialysis Prescriptions Promote Inadequate Treatment in Patients with Large Body Mass. Ann Intern Med [Internet]. 1998 Mar 15 [cited 2018 Sep 26];128(6):451. Available from: http://annals.org/article.aspx?doi=10.7326/0003-4819-128-6-199803150-00005 ; Alayoud A
Benyahia M
Montassir D
Hamzi A
Zajjari Y
Bahadi A
et al. A Model to Predict Optimal Dialysate Flow. Ther Apher Dial [Internet]. 2012 Apr [cited 2018 Sep 26];16(2):152–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22458394 ; Bhimani JP
Ouseph R
Ward RA. Effect of increasing dialysate flow rate on diffusive mass transfer of urea
phosphate and 2-microglobulin during clinical haemodialysis. Nephrol Dial Transplant [Internet]. 2010 Dec 1 [cited 2018 Sep 26];25(12):3990–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20543211 ; Yamamoto K-I
Matsukawa H
Yakushiji T
Fukuda M
Hiyoshi T
Sakai K. Technical Evaluation of Dialysate Flow in a Newly Designed Dialyzer. ASAIO J [Internet]. 2007 Jan [cited 2018 Sep 26];53(1):36–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17237647 ; Vanholder R
De Smet R
Argiles A
Baurmeister U
Brunet P
et al. Review on uremic toxins: classification
concentration
and interindividual variability. Kidney Int. 2003 May;63(5):1934–43. ; Ronco C. The Rise of Expanded Hemodialysis. Vol. 44
Blood purification. Switzerland; 2017. p. I–VIII. ; Cuenta de alto costo. Situación de la enfermedad renal crónica
Pokaż więcej
Temat :
Hemodiálisis expandida
Eemodiálisis expandida
Flujo de dializado (Qd)
Farmacología & terapéutica
Nefrología
Hemodiálisis-Investigaciones
Diálisis-Aparatos e instrumentos
Expanded hemodialysis
Dalysate flow (Qd)
Effectiveness of dialysis
Źródło :
reponame:Repositorio Institucional EdocUR ; instname:Universidad del Rosario ; Kashiwagi T, Sato K, Kawakami S, Kiyomoto M, Enomoto M, Suzuki T, et al. Effects of reduced dialysis fluid flow in hemodialysis. J Nippon Med Sch [Internet]. 2013 [cited 2018 Sep 26];80(2):119–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23657065 ; Tarrass F, Benjelloun M, Benjelloun O. Recycling Wastewater After Hemodialysis: An Environmental Analysis for Alternative Water Sources in Arid Regions. Am J Kidney Dis. 2008;52(1):154–8. ; Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet [Internet]. 2013 Jul 20 [cited 2018 Sep ....
Opis pliku :
application/pdf
Relacje :
https://repository.urosario.edu.co/handle/10336/20859
Dostępność :
https://doi.org/10.1016/j.ekir.2019.05.390
https://doi.org/10.1038/ki.1990.52
https://doi.org/10.1056/NEJMra0902710
https://doi.org/10.1111/j.1525-139X.2012.01107.x
https://doi.org/10.7326/0003-4819-128-6-199803150-00005
https://repository.urosario.edu.co/handle/10336/20859
Dysertacja/Praca dyplomowa
Tytuł :
Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection
Autorzy :
Trachtman, H
Frymoyer, A
Lewandowski, A
Greenbaum, LA
Feig, DI
Gipson, DS
Warady, BA
Goebel, JW
Schwartz, GJ
Lewis, K
Anand, R
Patel, UD
Pokaż więcej
Źródło :
Clinical Pharmacology & Therapeutics ; volume 98, issue 1, page 25-33 ; ISSN 0009-9236
Dostępność :
https://doi.org/10.1002/cpt.127
Czasopismo naukowe
Tytuł :
Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection
Autorzy :
Trachtman, H
Frymoyer, A
Lewandowski, A
Greenbaum, LA
Feig, DI
Gipson, DS
Warady, BA
Goebel, JW
Schwartz, GJ
Lewis, K
Anand, R
Patel, UD
Pokaż więcej
Relacje :
Trachtman, H; Frymoyer, A; Lewandowski, A; Greenbaum, LA; Feig, DI; Gipson, DS; Warady, BA; Goebel, JW; Schwartz, GJ; Lewis, K; Anand, R; Patel, UD (2015). "Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection." Clinical Pharmacology & Therapeutics 98(1): 25-33.; http://hdl.handle.net/2027.42/111964; Clinical Pharmacology & Therapeutics; Rhodin, M.M. et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr. Nephrol. 24, 67 – 76 ( 2009 ).; Cross, N.B., Webster, A.C., Masson, P., O'Connell, P.J. & Craig, J.C. Antihypertensives for kidney transplant recipients: systematic review and meta‐analysis of randomized controlled trials. Transplantation 88, 7 – 18 ( 2009 ).; Nielsen, S.E. et al. Neutrophil gelatinase‐associated lipocalcin (NGAL) and kidney injury molecule 1 (KIM1) in patients with diabetic nephropathy: a cross‐sectional study and the effects of lisinopril. Diabet. Med. 27, 1144 – 1150 ( 2010 ).; Inigo, P. et al. Effects of losartan and amlodipine on intrarenal hemodynamics and TGF‐β(1) plasma levels in a crossover trial in renal transplant recipients. J. Am. Soc. Nephrol. 12, 822 – 827 ( 2001 ).; Hernandez, A.A. et al. Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers in renal transplantation between 1990 and 2002 in Spain. NDT Plus 3 ( supp.l 2 ), ii21 – ii25 ( 2010 ).; Sorof, J.M., Goldstein, S.L., Brewer, E.D., Steiger, H.M. & Portman, R.J. Use of anti‐hypertensive medications and posttransplant renal allograft function in children. Pediatr. Transplant 4, 21 – 27 ( 2000 ).; Remuzzi, G., Benigni, A. & Remuzzi, A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J. Clin. Invest. 116, 288 – 296 ( 2006 ).; Knutter, I. et al. Transport of angiotensin‐converting enzyme inhibitors by H+/peptide transporters revisited. J. Pharmacol. Exp. Therap. 327, 432 – 441 ( 2008 ).; Hogg, R.J. et al. A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension. Pediatr. Nephrol. 22, 695 – 701 ( 2007 ).; Prinivil® (lisinopril tablets) [package insert]. Whitehouse Station, NJ: Merck & Co., Inc., 2003.; Qin, F., Wang, D., Yang, S., Jing, L., Xiong, Z. & Li, F. Quantitative determination of lisinopril in human plasma by high performance liquid chromatography‐tandem mass spectrometry and its application in a pharmacokinetic study. Biomed. Chromatogr. 26, 691 – 696 ( 2012 ).; Lin, J.H., Chen, I.W., Ulm, E.H. & Duggan, D.E. Differential handling of angiotensin‐converting enzyme inhibitors enalaprilat and lisinopril in rats. Drug Metab. Dispos. 16, 392 – 396 ( 1988 ).; U.S. Food and Drug Administration Clinical Pharmacology and Biopharmaceutics Review. CDER Approval Package for Prinivil®: Application Number 19‐558/S‐043. 2003. < http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/19-558S043_Prinivil.cfm >. Accessed 22 July, 2014.; Heads of Medicines Agencies. Lisinopril Paediatric Public Assessment Report: SE/W/002/pdWS/001.” 2009. < http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Paediatric_Regulation/Assessment_Reports/Article_45_work-sharing/Lisinopril_2009_11b_45PaedPAR.pdf >. Accessed 22 July, 2014.; Anderson, B.J. & Holford, N.H.G. Mechanism‐based concepts of size and maturity in pharmacokinetics. Ann. Rev. Pharmacol. Toxicol. 48, 303 – 332 ( 2008 ).; Holford, N., Heo, Y.A. & Anderson, B. A pharmacokinetic standard for babies and adults. J. Pharm. Sci. 102, 2941 – 2952 ( 2013 ).; Zestril® (lisinopril tablets) [package insert]. Wilmington, DE: AstraZeneca, 2009.; van Schaik, B.A., Geyskes, G.G., van der Wouw, P.A., van Rooij, H.H. & Porsius, A.J. Pharmacokinetics of lisinopril in hypertensive patients with normal and impaired renal function. Eur. J. Clin. Pharmacol. 34, 61 – 65 ( 1988 ).; Soffer, B., Zhang, Z., Miller, K., Vogt, B.A. & Shahinfar, S. A double‐blind, placebo‐controlled, dose‐response study of the effectiveness and safety of lisinopril for children with hypertension. Am. J. Hypertens. 16, 795 – 800 ( 2003 ).; Hermida, R.C. et al. Chronotherapeutics of conventional blood pressure‐lowering medications: a simple, low‐cost means of improving management and treatment outcomes of hypertensive‐related disorders. Curr. Hypertens. Rep. 16, 412 ( 2014 ).; Siddique, K., Leonard, D., Borders, L. & Seikaly, M.G. Validation of the CkiD formulae to estimate GFR in children post renal transplant. Pediatr. Nephrol. 29, 445 – 451 ( 2014 ).; Knoll, G.A. et al. The Canadian ACE‐inhibitor trial to improve renal outcomes and patient survival in kidney transplantation—study design. Nephrol. Dial. Transplant 23, 354 – 335 ( 2008 ).; ESCAPE Trial Group, et al. Strict blood‐pressure control and progression of renal failure in children. N. Engl. J. Med. 361, 1639 – 1650 ( 2009 ).; Schwartz, G.J. et al. New equations to estimate GFR in children. J. Am. Soc. Nephrol. 20, 629 – 637 ( 2009 ).; Mitsnefes, M.M., Khoury, P.R. & McEnery, P.T. Early post‐transplantation hypertension and poor long‐term renal allograft survival in pediatric patients. J. Pediatr. 143, 98 – 103 ( 2003 ).; Silverstein, D.M., LeBlanc, P., Hempe, J.M., Ramcharan, T. & Boudreaux, J.P. Tracking of blood pressure and its impact on graft function in pediatric renal transplant recipients. J. Pediatr. Transplant 11, 860 – 867 ( 2007 ).; Mitsnefes, M.M., Omoloja, A. & McEnery, P.T. Short‐term pediatric renal transplant survival: blood pressure and allograft function. Pediatr. Transplant 5, 160 – 165 ( 2001 ).
Dostępność :
https://doi.org/10.1002/cpt.127
http://hdl.handle.net/2027.42/111964
Tytuł :
Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C.
Autorzy :
Schwartz GJ
Schneider MF
Maier PS
Moxey-Mims M
Dharnidharka VR
Warady BA
Furth SL
Muñoz A
Schwartz, George J
Schneider, Michael F
Maier, Paula S
Moxey-Mims, Marva
Dharnidharka, Vikas R
Warady, Bradley A
Furth, Susan L
Muñoz, Alvaro
Pokaż więcej
Źródło :
Kidney International; Aug2012, Vol. 82 Issue 4, p445-453, 9p
Czasopismo naukowe
Tytuł :
Sleep and fatigue symptoms in children and adolescents with CKD: a cross-sectional analysis from the chronic kidney disease in children (CKiD) study.
Autorzy :
Roumelioti ME
Wentz A
Schneider MF
Gerson AC
Hooper S
Benfield M
Warady BA
Furth SL
Unruh ML
Roumelioti, Maria-Eleni
Wentz, Alicia
Schneider, Michael F
Gerson, Arlene C
Hooper, Stephen
Benfield, Mark
Warady, Bradley A
Furth, Susan L
Unruh, Mark L
Pokaż więcej
Źródło :
American Journal of Kidney Diseases; Feb2010, Vol. 55 Issue 2, p269-280, 12p
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies